Dextroamphetamine/Amphetamine National Contract
ID: SPE2D217D0061P00006Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/c1292db8bfb544efa6aa35b49ea22898/view
Timeline
    Description

    Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is a procurement notice from the DEFENSE LOGISTICS AGENCY, specifically the DLA TROOP SUPPORT office. This notice falls under the category of MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES with a PSC code of 6515. The primary contact for this contract is Denise Taubman, who can be reached at DENISE.TAUBMAN@DLA.MIL or 215-737-8677. The notice describes an amendment, P00006, which incorporates additional clauses to the existing contract.

    Point(s) of Contact
    DENISE TAUBMAN
    (215) 737-8677
    DENISE.TAUBMAN@DLA.MIL
    Files
    Title
    Posted
    SPE2D217D0061P00006 signed.pdf
    Lifecycle
    Title
    Type
    Dextroamphetamine/Amphetamine National Contract
    Currently viewing
    Special Notice
    Similar Opportunities
    Dextroamphetamine/Amphetamine National Contract
    Buyer not available
    Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is being modified to incorporate additional clauses to the contract. Dextroamphetamine/Amphetamine is a medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Please ensure the summary is concise and includes important entities such as locations, quantities, fulfillment requirements, sizes, etc.
    Dextroamphetamine/Amphetamine National Contract
    Buyer not available
    Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is being modified to change the address for Acetris. This contract is related to the procurement of medical and surgical instruments, equipment, and supplies. The place of performance for this contract is Monmouth Junction, NJ 08852, USA. For more information, please contact Denise Taubman at denise.taubman@dla.mil or 215-737-8677.
    SPE2D220R0063 BUPROPION XL AMENDMENT 0002
    Buyer not available
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking BUPROPION XL. This procurement is for drugs and biologicals under PSC code 6505. The primary contact for this procurement is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778) and the secondary contact is Denise Taubman (denise.taubman@dla.mil, 2157376877). The notice includes Amendment 0002, which incorporates telecommunication clauses. The solicitation is not reopened and the closing date is not extended. BUPROPION XL is typically used for medical purposes.
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    IBUPROFEN 400MG, 600MG, 800MG TABLETS NATIONAL CONTRACT
    Buyer not available
    Special Notice DEPT OF DEFENSE is seeking IBUPROFEN 400MG, 600MG, 800MG TABLETS. This medication is typically used for pain relief, reducing inflammation, and lowering fever. The notice is from the DEFENSE LOGISTICS AGENCY, DLA TROOP SUPPORT. The primary contact for this procurement is Denise Taubman (denise.taubman@dla.mil, 2157376877) and the secondary contact is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778). The notice includes AMENDMENT 00009 to incorporate telecommunication clauses into the solicitation.
    65--Manufacture/Distributor Br-Philadelp
    Buyer not available
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking a Manufacture/Distributor Br-Philadelp. This service/item is typically used for drugs and biologicals. The notice includes a modification that adds NDC 51407-0426-12 to CLIN 0006 of the contract. For more information, contact DENISE TAUBMAN at DENISE.TAUBMAN@DLA.MIL or 215-737-8677.
    LANSOPRAZOLE NATIONAL CONTRACT MODIFICATION
    Buyer not available
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is issuing a modification to the LANSOPRAZOLE NATIONAL CONTRACT. This modification aims to incorporate additional clauses to the existing contract. Lansoprazole is a medication used to treat stomach and esophagus problems such as acid reflux, ulcers, and gastroesophageal reflux disease (GERD). It belongs to a class of drugs known as proton pump inhibitors and helps reduce the amount of acid produced in the stomach. The modification to the contract will include the addition of specific clauses that may address various aspects such as pricing, delivery schedules, quality control, or any other relevant terms and conditions. For more information or inquiries, please contact Denise Taubman at DENISE.TAUBMAN@DLA.MIL or 2157378677.
    Lansoprazole Capsules
    Buyer not available
    The Defense Logistics Agency (DLA) is soliciting offers for the procurement of Lansoprazole DR 30MG capsules, a pharmaceutical product essential for treating various gastrointestinal conditions. This solicitation outlines the requirements for contractors to submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS), emphasizing compliance with Federal Acquisition Regulation (FAR) clauses and ethical business practices. The procurement is critical for maintaining the supply of necessary medications to support military personnel, ensuring adherence to stringent quality and legal standards. Interested contractors should direct inquiries to Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil, with submissions due by the specified deadline in the solicitation document.
    Oxycodone HCL Acetaminophen 325MG National Contract Solitiation
    Buyer not available
    Special Notice DEPT OF DEFENSE is seeking Oxycodone HCL Acetaminophen 325MG through a national contract solicitation. Oxycodone HCL Acetaminophen 325MG is a medication used for pain relief. The place of performance for this procurement is Weatherby, MO (zip code: 63119), USA. For more information, contact Denise Taubman at denise.taubman@dla.mil or 215-737-6877.
    Fluconazole - SPE2D221-D-0125-P00012 - Final Option Notice
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), has issued a special notice regarding the contract modification for Fluconazole under contract number SPE2D221-D-0125-P00012. This modification announces the exercise of the final option for the procurement of this pharmaceutical product, which is critical for various medical applications within military healthcare. Interested parties can reach out to the primary contact, Courtney Hunter-Stangler, at Courtney.Hunter-Stangler@dla.mil or by phone at 215-737-6845, or to the secondary contact, Jason Wray, at jason.wray@dla.mil or 215-737-0614, for further details regarding this opportunity.